Tramadol Hcl Tablet, Extended Release
Product Images NDC 80425-0136

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hcl (NDC 80425-0136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

A line graph depicting tramadol concentration (ng/mL) over 24 hours comparing Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily (q.d.) versus Tramadol Hydrochloride Tablets 50 mg every six hours (q6h). The graph shows tramadol levels fluctuating over time, with two distinct concentration profiles represented by filled and open circles.*

FDA Label Image

Fig 2

A line graph comparing M1 metabolite concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily versus Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis shows time in hours, and the y-axis shows M1 concentration levels.*

FDA Label Image

Fig 3

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various response thresholds of improvement from baseline. The x-axis represents response threshold as percent improvement (0-100%), and the y-axis shows percent of patients achieving response (0-60%). Lines represent Tramadol Hydrochloride Extended-Release Tablets at 100 mg, 200 mg, 300 mg, 400 mg, and placebo, illustrating patient response rates decreasing as threshold percentage increases.*

FDA Label Image

Fig 4

A line graph showing arthritis pain intensity response rates for Tramadol Hydrochloride Extended-Release Tablets versus placebo. The x-axis represents response threshold as percent improvement from baseline, and the y-axis shows the percent of patients achieving response. Two lines compare Tramadol ER (circle markers) and placebo (star markers), illustrating higher response rates across thresholds for Tramadol ER.*

FDA Label Image

Structure

Chemical structure of Tramadol Hydrochloride, showing its molecular arrangement including methoxy and hydroxyl groups, a cyclohexane ring, and dimethylamino methyl substituent.*

FDA Label Image

Tramadol HCl Er 200mg Tab Qty 60 Ndc 80425 0136

Label for Tramadol HCL ER 200 mg extended-release tablets, packaged by Advanced Rx Pharmacy of Tennessee, LLC in Nashville, TN. The label includes NDC 80425-0136-02, lot and expiration date (12/31/2023), and storage instructions (store at 20°-25°C). The label notes that the product is a prescription drug and cautions against unauthorized transfer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.